Global market for peripheral drug eluting balloons (DEBs) is poised for significant expansion, with projections indicating a robust growth trajectory over the forecast period from 2024 to 2031. According to latest market analysis, the peripheral DEB market size is expected to surge to US$1800 million by 2031, marking a substantial increase from the US$950 million recorded in 2024. This growth is anticipated to be driven by several key factors, including technological advancements, rising prevalence of Peripheral Artery Disease (PAD), and a growing preference for minimally invasive procedures.
For More Industry Insights Read: https://www.fairfieldmarketresearch.com/report/peripheral-drug-eluting-balloonsmarket
Steady Growth Trajectory and Key Market Dynamics The Global peripheral DEB market has witnessed consistent growth owing to advancements in cardiovascular treatment, increased prevalence of PAD, and a shift towards minimally invasive procedures. Between 2019 and 2023, the market demonstrated a positive trajectory with a projected Compound Annual Growth Rate (CAGR) of 9.56%. This growth is attributed to the efficacy of DEBs in reducing restenosis rates and the escalating demand for minimally invasive treatment options. Factors contributing to the continued growth of the market from 2024 to 2031 include ongoing advancements in cardiovascular treatment, a rising prevalence of PAD, and a preference for minimally invasive procedures among both patients and healthcare providers. However, significant barriers such as regulatory hurdles, limited clinical evidence, and cost constraints continue to influence adoption rates and reimbursement policies, shaping the market landscape.